SCHEMBL13820573

SCHEMBL13820573

c1ccc(-c2c(-c3cccc4ccccc34)c3ccccc3c3cc4c(-c5ccc6c(c5)sc5ccccc56)c5ccccc5c(-c5ccc6c(c5)sc5ccccc56)c4cc23)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F9 P00740 1/20 0.38
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
RAB9A P51151 1/20 0.36
ALOX5 P09917 1/20 0.35
GPR3 P46089 1/20 0.34
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
MCL1 Q07820 3/20 0.33
ACMSD Q8TDX5 1/20 0.33
ENPP1 P22413 1/20 0.33
CA12 O43570 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CA9 Q16790 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
SOS1 Q07889 1/20 0.32
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22178895 0.88 F9 (0.39) F9ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL20650671 0.87 ALDH1A1 (0.44) F9ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL23502120 0.86 ALDH1A1 (0.39) F9ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL23427357 0.86 F9 (0.37) F9ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL23502249 0.86 ALDH1A1 (0.39) F9ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL23428382 0.86 F9 (0.37) F9ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL21687004 0.86 ALDH1A1 (0.41) F9ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL13820526 0.86 ALDH1A1 (0.41) F9ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL17944589 0.86 ALDH1A1 (0.41) F9ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL20650846 0.86 F9 (0.43) F9ALDH1A1MAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120286251-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2012-11-15 US disclosed
US-20120286251-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2012-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120286251-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, LEF1, OR51E2 F9 1148/4885ALDH1A1 20/4885MAPT 1302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.